SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-24-000470
Filing Date
2024-08-15
Accepted
2024-08-15 20:12:33
Documents
1
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5605
  Complete submission text file 0000904454-24-000470.txt   8328
Mailing Address C/O SOLAR CAPITAL LLC 500 PARK AVENUE, 5TH FLOOR NEW YORK NY 10022
Business Address
Potter Leonard (Reporting) CIK: 0001476217 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42253 | Film No.: 241213906

Mailing Address 888 SEVENTH AVENUE 37TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 37TH FLOOR NEW YORK NY 10106 212-468-5100
Wildcat Capital Management, LLC (Reporting) CIK: 0001582384 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1213
Type: 3 | Act: 34 | File No.: 001-42253 | Film No.: 241213908

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102 817-871-4000
Wildcat Partner Holdings, LP (Reporting) CIK: 0001633223 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42253 | Film No.: 241213907

Mailing Address 250 PARK AVENUE, 7TH FLOOR NEW YORK NY 10177
Business Address 250 PARK AVENUE, 7TH FLOOR NEW YORK NY 10177 212-572-6395
Biomotion Sciences (Issuer) CIK: 0002022416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)